These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 18661528)
1. The case for prostate-specific antigen screening starting at age 40. Nadler RB Cancer; 2008 Sep; 113(6):1278-81. PubMed ID: 18661528 [No Abstract] [Full Text] [Related]
2. Weighing the benefits and downsides of prostate-specific antigen screening. Pignone M Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672 [No Abstract] [Full Text] [Related]
7. Re: prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable. Yuen JS J Urol; 2004 Mar; 171(3):1246. PubMed ID: 14767320 [No Abstract] [Full Text] [Related]
9. Prostate cancer screening. Med Lett Drugs Ther; 2008 Nov; 50(1298):85-6. PubMed ID: 18978703 [No Abstract] [Full Text] [Related]
10. Upcoming evidences on prostate-specific antigen-based screening for men at risk of prostate cancer. Boscolo-Berto R Int J Urol; 2009 Sep; 16(9):711. PubMed ID: 19769655 [No Abstract] [Full Text] [Related]
11. Prostate specific antigen screening and active surveillance in the elderly. Konety BR J Urol; 2009 Apr; 181(4):1534-5. PubMed ID: 19230925 [No Abstract] [Full Text] [Related]
12. Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan. Ito K; Kakehi Y; Naito S; Okuyama A; Int J Urol; 2008 Sep; 15(9):763-8. PubMed ID: 18786203 [TBL] [Abstract][Full Text] [Related]
14. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country. Kuo NW; Lin HC; Lee HC J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533 [TBL] [Abstract][Full Text] [Related]
15. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter. Stephan C; Jung K Eur Urol; 2008 Aug; 54(2):369-70. PubMed ID: 18006212 [No Abstract] [Full Text] [Related]
16. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter. Froehner M Eur Urol; 2008 Aug; 54(2):368-9. PubMed ID: 18006213 [No Abstract] [Full Text] [Related]
17. Prostate screening frequency questioned. Health News; 2002 Jul; 8(7):9. PubMed ID: 12132511 [No Abstract] [Full Text] [Related]
18. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues. Ito K Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638 [No Abstract] [Full Text] [Related]
19. In this issue: mini-theme on geriatric care and cancer screening. Bowman MA; Neale AV J Am Board Fam Med; 2009; 22(3):231-3. PubMed ID: 19429726 [No Abstract] [Full Text] [Related]
20. [PSA based screening for prostatic cancer]. Johansen TE Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357 [No Abstract] [Full Text] [Related] [Next] [New Search]